Barbara Klencke is a director of Tscan Therapeutics Inc.
Person profile
Roles
Address
Vancouver, British Columbia, Canada
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
eFFECTOR Therapeutics, Inc.
21 Feb 24
4
TScan Therapeutics, Inc.
18 Dec 23
4
Xencor Inc
19 Sep 23
3
Xencor Inc
19 Sep 23
4
eFFECTOR Therapeutics, Inc.
22 Jun 23
4
TScan Therapeutics, Inc.
15 Jun 23
4
TScan Therapeutics, Inc.
10 Apr 23
3
TScan Therapeutics, Inc.
10 Apr 23
4
eFFECTOR Therapeutics, Inc.
24 Jan 23
4
Sierra Oncology, Inc.
1 Jul 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Dec 23 | TCRX Tscan Therapeutics | Voting Common Stock | Buy | Acquire P | No | No | 5.08 | 5,000 | 25.40 k | 30,000 |
15 Sep 23 | XNCR Xencor | Stock Option Common Stock | Grant | Acquire A | No | No | 20.69 | 40,070 | 829.05 k | 40,070 |
22 Jun 23 | EFTR eFFECTOR Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.8152 | 20,000 | 16.30 k | 20,000 |
13 Jun 23 | TCRX Tscan Therapeutics | Stock Option Voting Common Stock | Grant | Acquire A | No | No | 2.66 | 36,524 | 97.15 k | 36,524 |